Breaking News

ADC Bio’s New State of the Art Cleanroom Competed by WHP

The GMP facility has been designed to deliver next gen anticancer blockbuster ADC drugs for patients globally

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility, designed and built by WHP. This forms a key part of ADC Bio’s construction of a new bioconjugation facility at its site in Deeside, North Wales, UK for the commercial production of antibody drug conjugates in response to global customer demand.   Antibody drug conjugates (ADCs) are a class of emerging biotherapeutics that require a bespoke infrastruc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters